AbCellera Biologics Other Current Assets

As of the most recent data (June 2026), ABCL shows a other current assets of $36M. That compares with $36M in the prior-year period — up 1.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ABCL's other current assets is now $36M (was $36M) — a 1.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether AbCellera Biologics is outperforming or lagging.

Tracking ABCL's other current assets over time shows whether AbCellera Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $36M That compares with $36M in the prior-year period — up 1.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has AbCellera Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $36M) with ownership activity and broader fundamentals.